In neighbourhoods across Nigeria, a new kind of medicine seller has become impossible to miss. They do not operate from pharmacies with registered pharmacists and regulated stock. They are not bound by the formal supply chains that distribute conventional pharmaceuticals through licensed outlets. They are operating in open markets, on social media platforms, and increasingly through messaging applications where their products arrive as recommendations based on browsing history, location data, and what appears to be an increasingly sophisticated understanding of which health anxieties are most prevalent in which communities.
The phenomenon is being described by researchers and health regulators as the rise of Nigeria algorithmic apothecary a system in which artificial intelligence tools are used to target vulnerable patients with herbal and alternative treatments that may carry real risks. The products range from well-established traditional remedies with documented efficacy to entirely unverified compounds marketed with claims that would require clinical trial data to support. Some work. Others do not. A smaller number cause harm sometimes because the compounds themselves are dangerous, sometimes because patients delay seeking evidence-based treatment while trying remedies that are not delivering results.
The Mechanics of Algorithmic Health Marketing
The mechanics of algorithmic health marketing are not unique to Nigeria, and the phenomenon is a variant of a global challenge around digital health misinformation. What makes the Nigerian case distinctive is the scale of informal healthcare-seeking behaviour, the relatively weak enforcement capacity of regulatory bodies, and the particular desperation that exists in communities where the formal health system is either too expensive or too distant to access quickly.
Social media platforms allow herbal product sellers to create targeted advertising campaigns that reach specific demographic groups in specific locations, with messages calibrated to the health conditions those groups are most likely to be researching online. Someone who has been searching for diabetes management information in Lagos will see advertisements for herbal compounds marketed as blood sugar regulators. Someone in the north researching fertility treatments will be targeted with entirely different products. The system is not random it is a deliberate commercial architecture built on personal health data.
The Regulatory Gap
Nigeria National Agency for Food Drug Administration and Control has stated that it is working to address the proliferation of unregistered health products sold through digital channels, but the scale of the challenge has consistently outpaced enforcement capacity. The agency has issued warnings about specific products, conducted raids on market stalls, and prosecuted individual sellers. But the digital marketplace operates across multiple platforms, multiple jurisdictions, and often through seller networks that dissolve and reappear under new names.
The deeper problem is that regulatory frameworks designed for physical markets are structurally illequipped to handle a digital marketplace where products change names, formulations, and branding faster than inspection schedules can track them. What NAFDAC is confronting is not simply a compliance problem it is a technological arms race between regulators trying to enforce rules designed for a different era and commercial actors who have adopted the most powerful tools of the digital age for health product marketing.
The Human Cost
The human consequences of the algorithmic apothecary are difficult to quantify precisely because the system operates largely outside formal medical reporting structures. Cases of adverse reactions to herbal compounds are not systematically tracked when those compounds have never been formally registered or recognised as medicinal products. Patients who experience negative outcomes from untested herbal treatments are often treated in hospitals without the medical system ever knowing what they consumed before arriving.
What is clear from available data is that certain categories of health complaint diabetes management, fertility treatment, pain management, anxiety and depression are the most heavily targeted by herbal product marketing campaigns and also the areas where delay in receiving evidence-based care causes the most harm. A diabetic who abandons their prescribed medication in favour of an unregulated compound marketed through social media does not immediately feel the consequences. The consequences arrive months or years later, in emergency rooms, with complications that are significantly harder and more expensive to treat.
What Solutions Look Like
Health policy experts say the solution requires multiple interventions operating simultaneously. Regulatory bodies need technological capacity to monitor digital marketplaces in real time, not just respond to complaints after products have been widely distributed. Digital platforms have responsibilities to prevent their infrastructure from being used to spread harmful health misinformation, and the argument for holding them accountable is growing stronger as evidence of harm accumulates. And at the community level, health education initiatives need to address the underlying trust gaps that make unregulated herbal remedies attractive alternatives to formal healthcare.
The algorithmic apothecary is not a problem that will be solved by any single intervention. It is a structural feature of Nigeria fragmented healthcare landscape a symptom of a system where access to quality care is uneven, where regulatory capacity is stretched, and where digital tools have outpaced the governance frameworks meant to protect citizens from their misuse. Until those structural conditions change, the market for unregulated health products will continue to find new ways to reach the people who are most vulnerable to its appeals.
